Correction: Telehealth Utilization and Modality Selection in US Adults: A Shorrocks-Shapley Decomposition of a 2022 National Cross-Sectional Survey

By
Corneliu Bolbocean
Corey Hayes
Cari Bogulski
October 15, 2026

Journal Of Medical Internet Research

Overview

The correction notice addresses errors in descriptive statistics in Table 1 and the Results section of a national cross-sectional survey of telehealth modality selection among US adults. The authors state that the analytic sample, survey-weighted prevalence estimates, decomposition, regression models, findings, and conclusions are unchanged.

Background

Telehealth use and choice of modality are relevant to understanding how adults access health care. The corrected article examined modality selection among US adults using a 2022 national cross-sectional survey and a Shorrocks-Shapley decomposition. The notice reports that some descriptive counts were presented using derived numerators rather than observed unweighted counts, and that a Table 1 footnote incorrectly described percentages as survey-weighted. It distinguishes these presentation corrections from the analyses and conclusions, which the authors report remain unchanged.

Data Highlights

Item	Correction notice detail
Survey-weighted prevalence estimates	27.2%, 12.1%, and 60.7%; unchanged
Table 1 descriptive statistics	Some dual-numerator constructions used derived numerators instead of observed unweighted counts
Table 1 footnote	Corrected because percentages had been incorrectly characterized as survey-weighted
Results section	Numerical text corrections were made; the notice states the Results section is otherwise unchanged
Analyses and conclusions	Analytic sample, group definitions, decomposition, regression models, findings, and conclusions remain unchanged

Key Findings

The underlying study examined telehealth modality selection among US adults using a 2022 national cross-sectional survey.
The correction concerns descriptive presentation in Table 1 and numerical statements in the Results section.
Some Table 1 dual-numerator constructions used derived numerators—observed percentages rescaled to full group denominators—in place of observed unweighted counts.
The Table 1 footnote was corrected because it had incorrectly characterized the percentages as survey-weighted.
The survey-weighted prevalence estimates of 27.2%, 12.1%, and 60.7% were not changed.
The authors report that the analytic sample, group definitions, Shorrocks-Shapley decomposition, regression models in Tables 2 and 3, and all findings and conclusions remain unchanged.

Clinical Implications

The correction notice does not report changes to the study’s analyses or conclusions and does not provide new clinical recommendations. Readers using the article should consult the corrected version for the revised descriptive statistics and Results text.

Conclusion

The notice corrects descriptive and numerical reporting in the 2022 survey article while stating that its analytic results and conclusions are unchanged. The corrected paper was resubmitted to PubMed, PubMed Central, and other full-text repositories.